PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 203 filers reported holding PDL BIOPHARMA INC in Q2 2016. The put-call ratio across all filers is 2.73 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $7,000 | +16.7% | 2,000 | 0.0% | 0.00% | – |
| Q2 2016 | $6,000 | -57.1% | 2,000 | -50.0% | 0.00% | – |
| Q1 2016 | $14,000 | +100.0% | 4,000 | +100.0% | 0.00% | – |
| Q4 2015 | $7,000 | -30.0% | 2,000 | 0.0% | 0.00% | – |
| Q3 2015 | $10,000 | -23.1% | 2,000 | 0.0% | 0.00% | – |
| Q2 2015 | $13,000 | -7.1% | 2,000 | 0.0% | 0.00% | – |
| Q1 2015 | $14,000 | -6.7% | 2,000 | 0.0% | 0.00% | – |
| Q4 2014 | $15,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q3 2014 | $15,000 | -21.1% | 2,000 | 0.0% | 0.00% | – |
| Q2 2014 | $19,000 | +11.8% | 2,000 | 0.0% | 0.00% | – |
| Q1 2014 | $17,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q4 2013 | $17,000 | +6.2% | 2,000 | 0.0% | 0.00% | – |
| Q3 2013 | $16,000 | +6.7% | 2,000 | 0.0% | 0.00% | – |
| Q2 2013 | $15,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |